4 Mins Read Ginkgo Bioworks, the Boston-based synbio startup, has gone public on the NYSE and raised $1.6 billion to fuel its cell programming platform.

The post Ginkgo Bioworks Goes Public, Looks To Grow Cell Programming Platform appeared first on Green Queen.

This post was originally published on Green Queen.